These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene therapy approaches for the prevention of restenosis. Kopp CW; de Martin R Curr Vasc Pharmacol; 2004 Apr; 2(2):183-9. PubMed ID: 15320519 [TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide-based molecular therapy for restenosis after angioplasty. Aoki M; Morishita R; Ogihara T Curr Drug Targets; 2003 Nov; 4(8):613-8. PubMed ID: 14577651 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy for coronary restenosis: is the enthusiasm justified? O'Sullivan M; Bennett MR Heart; 2001 Nov; 86(5):491-3. PubMed ID: 11602536 [No Abstract] [Full Text] [Related]
7. Antisense therapy for restenosis following percutaneous coronary intervention. Kipshidze N; Tsapenko M; Iversen P; Burger D Expert Opin Biol Ther; 2005 Jan; 5(1):79-89. PubMed ID: 15709911 [TBL] [Abstract][Full Text] [Related]
8. [Gene therapy in interventional coronary interventions]. Buchwald AB Herz; 2002 Sep; 27(6):533-8. PubMed ID: 12378399 [TBL] [Abstract][Full Text] [Related]
9. Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. Deiner C; Schwimmbeck PL; Koehler IS; Loddenkemper C; Noutsias M; Nikol S; Schultheiss HP; Ylä-Herttuala S; Pels K Atherosclerosis; 2006 Nov; 189(1):123-32. PubMed ID: 16434047 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. Bennett MR; O'Sullivan M Pharmacol Ther; 2001 Aug; 91(2):149-66. PubMed ID: 11728607 [TBL] [Abstract][Full Text] [Related]
12. Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology. Mitra AK; Agrawal DK Pharmacogenomics; 2006 Dec; 7(8):1185-98. PubMed ID: 17184206 [TBL] [Abstract][Full Text] [Related]
13. [Gene therapy of restenosis and atherosclerosis: hopes and facts]. Mazighi M; Tchétché D; Hyafil F; Feldman LJ Pathol Biol (Paris); 2004 May; 52(4):212-7. PubMed ID: 15145134 [TBL] [Abstract][Full Text] [Related]
14. Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis. Fishbein I; Guerrero DT; Alferiev IS; Foster JB; Minutolo NG; Chorny M; Monteys AM; Driesbaugh KH; Nagaswami C; Levy RJ Gene Ther; 2017 Nov; 24(11):717-726. PubMed ID: 28832561 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for restenosis: biological solution to a biological problem. Kishore R; Losordo DW J Mol Cell Cardiol; 2007 Mar; 42(3):461-8. PubMed ID: 17222423 [TBL] [Abstract][Full Text] [Related]
16. The emerging role of gene therapy in the treatment of cardiovascular diseases. Barbato JE; Kibbe MR; Tzeng E Crit Rev Clin Lab Sci; 2003 Oct; 40(5):499-545. PubMed ID: 14653356 [TBL] [Abstract][Full Text] [Related]
17. Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine. Hall S; Agrawal DK Drug Deliv Transl Res; 2018 Aug; 8(4):918-927. PubMed ID: 28707263 [TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury. Han XJ; Chen M; Hong T; Zhu LY; He D; Feng JG; Jiang LP Int J Mol Med; 2015 Apr; 35(4):885-92. PubMed ID: 25625334 [TBL] [Abstract][Full Text] [Related]